AKT1 and leukemia: Similarly, TQ reduced the phosphorylation and the protein expression level of Akt in ML-1, MV4-11, and Kasumi-1 leukemia cells [24], MDA-MB-231, and MDA-MB-436 triple-negative breast cancer (TNBC) cells [25], and Her2+ and Her2− breast cancer cells [37].